MedPath

LAMIVUDINA/ZIDOVUDINA TEVA 150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

LAMIVUDINA/ZIDOVUDINA TEVA 150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

10663001

Prescription Type

Uso Hospitalario

Authorization Date

Apr 12, 2011

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number10663001
EMA Approved
Yes

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

LAMIVUDINAActive
Quantity: 150 mg
Name: LAMIVUDINA
ZIDOVUDINAActive
Quantity: 300 mg
Name: ZIDOVUDINA

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.